Director · Karyopharm Therapeutics Inc. · Common Stock
Side
A
Value
—
Shares
15.5K
Price
—
Executed
May 21, 2026
Disclosed
May 26, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
May 21 executedMay 26, 2026 disclosed
KPTI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Su Zhen filed this Form 4 reporting a grant or award of KPTI on May 21, 2026. It became public on May 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Su Zhencik:0001991642
Issuer
Karyopharm Therapeutics Inc.cik:0001503802
Revision history · 0
No field has changed since this record was first ingested.
